Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 11/20 | 0.65 |
| ▸ | ITGA5 | P08648 | 4/20 | 0.65 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.60 |
| ▸ | ITGA4 | P13612 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | ITGAV | P06756 | 4/20 | 0.55 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690681 | 0.92 | ITGB1 (0.64) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL6708383 | 0.91 | ITGB1 (0.63) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL5691016 | 0.90 | ITGB1 (0.59) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL5690234 | 0.88 | FKBP1A (0.66) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL5690742 | 0.88 | ITGB1 (0.71) | ITGB1ITGA5ITGA4ALDH1A1ITGAV | |
| SCHEMBL6710892 | 0.88 | ALDH1A1 (0.70) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL27514023 | 0.88 | ALDH1A1 (0.70) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL7066469 | 0.88 | ALDH1A1 (0.70) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL7069740 | 0.88 | ALDH1A1 (0.70) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 | |
| SCHEMBL6439213 | 0.88 | ALDH1A1 (0.70) | ITGB1ITGA5FKBP1AITGA4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001974-B1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARM INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-6291453-B1 | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | ATHENA NEUROSCIENCES, INC. | 2001-09-18 | — | — | US | claimed |
| EP-1001974-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999006434-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | claimed |
| EP-1001974-B1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARM INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-6291453-B1 | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | ATHENA NEUROSCIENCES, INC. | 2001-09-18 | — | — | US | disclosed |
| EP-1001974-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999006434-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | disclosed |